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ABSTRACT 
Objective: Studies were carried out, for the first time, to investigate the charge-transfer reactions of voriconazole antifungal drug (VOR) as n-
electron donor with the σ-acceptor iodine (I
, health informatics Umm al-Qura, university, Makkah, Saudi Arabia. 
Email: aymangouda77@gmail.com  
2) and various π-acceptors: 7,7,8,8-tetracyanoquinodimethane (TCNQ); 2,3-dichloro-5,6-dicyano-1,4-
benzoquinone (DDQ) and p-chloranilic acid (p-CLA).  
Methods: The formation of the colored charge-transfer complexes were utilized in the development of simple, rapid and accurate 
spectrophotometric methods for the analysis of voriconazole in pure form as well as in its pharmaceutical formulation (tablets). Different variables 
affecting the reactions were studied and optimized.  
Results: Under the optimum reaction conditions, linear relationships with good correlation coefficients (0.9994–0.9999) were found between the 
absorbance and the concentration of voriconazole in the range of 2.0–120 μg mL−1. For more accurate analysis, Ringbom optimum concentration 
range was found to be between 4.0-110 μg mL-1. The limits of detection ranged from 0.36 to 1.23 μg mL−1andthe limits of quantification ranged from 
1.20 to 4.10 μg mL−1
Keywords: Voriconazole, Charge-transfer complexes, Spectrophotometry; Pharmaceutical formulations. 
. A Job's plot of the absorbance versus the molar ratio of voriconazole to each of acceptors under consideration indicated (1:1) 
ratio.  
Conclusion: The proposed methods were applied successfully for simultaneous determination of voriconazole in tablets with good accuracy and 
precision and without interferences from common additives. The results were compared favourably with the reported method. 
 
INTRODUCTION 
Voriconazole (VOR) is a triazole antifungal that is a derivative of 
fluconazole. It is chemically (2R, 3S)-2-(2,4-difluorophenyl)-3-(5-
fluoro pyrimidin-4-yl) -1- (1,2,4-triazol-1-yl) butan- 2-ol (Figure. 1) 
[1]. Like all azole antifungals, its mechanism of action is the 
inhibition of a cytochrome P-450-dependent enzyme, 14-á-sterol 
demethylase that is essential to the synthesis of ergosterol for the 
fungal cell membrane. This inhibition is more selective for fungal 
than for mammalian enzyme systems. The accumulation of 14-
alphamethyl sterols results in a decrease in ergosterol, which is an 
essential component of fungal cell wall formation. The resulting cell 
wall abnormalities are thought to be responsible for VOR's 
antifungal activity. VOR was approved by the Food and Drug 
Administration in May, 2002 for the treatment of invasive 
aspergillosis and refractory infections of scedo sporiuma 
piospermum and fusarium. Studies have also shown it to be a 
promising agent for empiric treatment in febrile neutropenia.  
 
Fig. 1: The chemical structure of VOR 
 
Literature survey revealed that a few analytical methods have been 
reported for the determination of VOR in pure drug, pharmaceutical 
dosage forms and in biological samples using liquid chromatography 
either in single or in combined forms [2-13], Electrochemical 
methods [14, 15] and spectrophotometric methods [16-19]. 
Visible spectrophotometry, because of simplicity and cost 
effectiveness, sensitivity and selectivity, fair accuracy, precision and 
available in most quality control laboratories, has remained 
competitive in an area of chromatographic techniques for 
pharmaceutical analysis. Furthermore, they do not need costly 
instrumentation required for published HPLC methods. 
The molecular interactions between electron donors and acceptors 
are generally associated with the formation of intensely colored 
charge transfer complexes, which absorb radiation in the visible 
region [20]. A variety of electron donating compounds have been 
reported to yield charge-transfer complexes with various acceptors. 
The rapid formation of these complexes leads to their utility in the 
development of simple and convenient spectrophotometric methods 
for these compounds [21-27]. 
VOR is a good n-electron donor and will form charge transfer complexes 
with σ-acceptor like iodine (I2
All absorption spectra were made using the double beam Unikon 
930 spectrophotometer (Kontron Instruments, Munchen, Germany) 
) and π-acceptors such as 7,7,8,8-
tetracyanoquinodimethane (TCNQ); 2,3-dichloro-5,6-dicyano-1,4-
benzoquinone (DDQ) and p-chloranilic acid (p-CLA); are known to yield 
charge transfer complexes and radical anions. The charge-transfer 
reaction has not yet been reported for VOR; therefore the aim of the 
present study was directed to investigate simple, direct, sensitive and 
precise spectrophotometric methods for simultaneous determination of 
VOR via complexation with σ- and π -acceptors in pure form and its 
pharmaceutical formulations (tablets). 
MATERIALS AND METHODS 
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with a scanning speed of 200 nm/min and a bandwidth of 2.0 nm, 
equipped with 10 mm matched quartz cells. 
Materials and reagents 
Materials 
Pure grade voriconazole (VOR) was kindly supplied by Sigma Co. its 
potency was (99.38 ± 0.92%). 
Pharmaceutical formulations 
Vfend® tablets labeled to contain (200 mg VOR / tablet), purchased 
from Pfizer Pharmaceuticals Co. Ltd., USA.  
Preparation of stock standard solution 
Standard stock solution of VOR (1.0 mg mL-1) was prepared by 
accurately weighting and dissolving 100 mg of VOR in 2.0 mL 
methanol in a 100 mL calibrated flask and completed to volume with 
the same solvent (for DDQ), with 1,2-dichloroethane (for I2), and 
with acetonitrile (for the other acceptors, TCNQ and p-CLA). These 
stock solutions were diluted with the respective solvents to obtain 
suitable concentrations that lie in the linear range of each particular 
assay method, In the same manner, stock solution of 1.0 x 10-3 M of 
the drug was also prepared. The solutions were stable for at least 
one week at 4 °C. 
Reagents 
All reagents and solvents used were of analytical-reagent grade. 
- Iodine resublimed, (Riedel De-Haen, Germany) (1.0 x 10-3 M) in 1,2-
dichloroethane was prepared. the solution was stable for at least one 
week at 4 °C.  
- 7,7,8,8-tetracyanoquinodimethane (TCNQ), (Aldrich Chem. Co., 
Milwaukee, USA) and p-Chloranilic acid (p-CLA), (Fluka, 
Switzerland), (1.0 x 10-3 M) were prepared in acetonitrile, the 
solutions were stable for at least one week at 4 °C. 
- 2,3-Dichloro-5,6-dicyano-p-benzoquinone (DDQ), (Merck-
Schuchardt, Munich, Germany) (1.0 x 10-3 M) was prepared in 
methanol, the solutions were prepared fresh daily and were stable 
for at least one week at 4°C.  
General analytical procedure 
Into 10-mL calibrated flasks were placed aliquot volumes (0.2-3.0 
mL) of 100 μg mL−1 VOR in 1,2-dichloroethane for I2, (0.1-1.8 mL) of 
500 μg mL−1 VOR in methanol for DDQ, (0.1-2.5 mL) of 500 μg mL−1 
VOR in acetonitrile for p-CLA and (0.1-1.0 mL) of 200 μg mL−1 VOR 
200 μg mL−1 VOR in acetonitrile for TCNQ. 1.0 and 2.0 mL of (1.0 x 
10-3 M) TCNQ and (I2, DDQ and p-CLA), respectively was added. The 
reaction mixture was allowed to stand for 5.0 min at (25 ± 2 °C) in 
case of DDQ or p-CLA; the reaction mixture was heated in a water-
bath at 60±2ºC for 10 min in case of TCNQ and the reaction in case of 
I2 was achieved instantaneously. The volume was made up 10 mL 
with methanol for DDQ, 1,2-dichloroethane for I2 and with 
acetonitrile for DDQ and p-CLA. The absorbance of the resulting 
solutions was measured at the wavelengths of maximum absorption 
364, 840, 461 and 538 nm for I2
Job's method of continuous variation [28] was employed, a 1.0 x 10
, TCNQ, DDQ and p-CLA, respectively 
against the reagent blank prepared in the same manner. 
Procedure for determination of VOR in tablets 
Twenty tablets of the drug were weighed and a quantity of the 
content tablets equivalent to 100 mg was transferred into a 50-mL 
calibrated flask, dissolved in 2.0 mL methanol, swirled and sonicated 
for 5.0 min, completed to volume with the corresponding solvent (as 
in stock solutions), shaken well for 10 min, and filtered. The first 
portion of the filtrate was rejected, and a measured volume of the 
filtrate was diluted quantitatively with a suitable solvent to yield 
suitable concentrations lie in the linear range of each particular 
assay method; then the procedure was followed as above. 
Determination of molar ratio of reactants in complex 
-3 
M standard solution of drug and reagents were used. A series of 
solutions were prepared in which the total volume of VOR and 
reagent was constant (2.0 mL). The drug and reagents were mixed in 
various complementary proportions (0:10, 1:9,…, 9:1, 10:0, 
inclusive) and then diluted in a 10-mL calibrated flask with the 
optimum solvent. The reactions were allowed to proceed for the 
optimum reaction time (Table 1) and the absorbance of the resulting 
solutions was measured at the corresponding wavelengths of 
maximum absorbance (λmax) against a reagent blank under the same 
conditions. 
Association constant 
Serial volumes of 1.0-5.0 mL of 1.0 x 10-3 M VOR solution (in 1.0 mL 
steps) in the optimum solvent were transferred in 10-mL calibrated 
flasks. To each flask, 1.0 mL of acceptor solution (1.0 x 10-3
Spectral characteristics of the reaction 
 M) was 
added and continued as directed under the general procedure. 
RESULTS  
Reaction with σ-acceptor (iodine) 
The color of iodine in 1,2-dichloroethane is violet showing 
absorption maximum (λmax) at 520 nm. This color was immediately 
changed into lemon yellow, and the absorption spectrum of VOR-I2 
reaction product showed absorption peaks at 292 and 364 nm. This 
change in color, and the appearance of these two peaks were 
attributed to the formation of charge-transfer complex between the 
VOR and I2, having an ionized structure DI+ … I3−, taking into account 
that the absorption spectrum of I3 − in 1,2-dichloroethane showed 
the two absorption maxima at 292 and 364 nm. This complex should 
originate from an early intermediate outer complex D…I2, according 
to the following scheme 
 
Further confirmation for the charge-transfer nature of the reaction, 
VOR was extracted from the complex by shaking with aqueous 
mineral acids. The color of iodine in 1,2-dichloroethane layer was 
restored to violet, confirming the charge-transfer nature of the 
reaction. Measurements were carried out at 364 nm due to the 
interference from the native UV absorption of VOR at 256 nm. 
Reaction with π-acceptors 
The interaction of VOR with selective polyhaloquinone and 
polycyanoquinone π-acceptors in non-polar solvents such as 1,2-
dichloroethane was found to produce colored charge-transfer 
complexes with low molar absorptivity values. In polar solvents such 
as methanol or acetonitrile, complete electron transfer from the VOR 
(D), as an electron donor, to the acceptor moiety (A) takes place with 
the formation of intensely colored radical ions with high molar 





DA complexDonor Acceptor  
The dissociation of the (D–A) complex was promoted by the high 
ionizing power of the polar solvent and the resulting peaks in the 
absorption spectra of VOR-acceptor reaction mixtures were similar 
to the maxima of the radical anions of the acceptors obtained by the 
iodide reduction method [29]. 
The interaction of VOR with π-acceptors at optimum temperature 
gave colored chromogens showing different absorption maxima at 
538, 461 and 840 nm for DDQ, p-CLA and TCNQ, respectively (fig. 2, 
3 and 4). 
The resulting maxima of the investigated drug with DDQ and p-CLA 
are similar to that of the radical anion of these acceptors obtained by 
the reduction method and coincide with the values reported in 
previous work [30]. 
The predominent chromogen with TCNQ in acetonitrile is the bluish-
green colored radical anion, which exhibits strong absorption 
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maxima at 840, 825, 762, and 742 nm. These bands may be 
attributed to the formation of the radical anion TCNQ −, which was 
probably formed by the dissociation of an original donor–acceptor 
(D–A) complex with VOR. The dissociation of the complex was 
promoted by the high ionizing power of acetonitrile. 
 
Fig. 2: Absorption spectra of DDQ and the reaction product of 90 
μg mL−1 VOR in methanol 
 
 
Fig. 3: Absorption spectra of P-CLA and the reaction product of 
120 μg mL−1 VOR in acetonitrile 
 
 
Fig. 4: Absorption spectra of TCNQ and the reaction product of 
20 μg mL−1
Chloranilic acid (p-CLA) exists in three ionic forms, the neutral 
yellow-orange H
 VOR in acetonitrile 
 
Further support of this assignment was provided by the absorption 
maxima with those of TCNQ radical anion produced by the iodide 
reduction method [31]. 
2A at very low pH, the dark purple HA− which is 
stable at pH 3.0 and a colorless A2−
H
, which is stable at high pH; these 
transformations are illustrated in the following scheme:  
2A H++HA−  (violet),
HA− H++A2−  
Since the interaction of VOR with p-CLA in acetonitrile gave a violet 
product, it might be concluded that HA
(colorless).
−
Effect of reagent concentration 
The results for variation of reagent concentration, indicated that 1.0 
and 2.0 mL of (1.0 x 10
 was the form of p-CLA 
involved in the reaction described herein. 
The relative higher molar absorptivities and sensitivity of the four 
acceptors employed in the present analytical work may be 
attributed to their difference in electron affinities, as well as the 
conditions employed in the reaction (reagent concentration, reaction 
time, and solvent).  
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, p-CLA or TCNQ) and DDQ, 
respectively are suitable. The higher concentrations of the reagents 
may, on the other hand, be useful for rapidly reaching equilibrium 
and complete color development, the results are given in (fig. 5). 
This minimizes the time required to attain the maximum absorbance 
at the corresponding wavelength of the charge transfer complexes. 
 
 
Fig. 5: Effect of reagent concentration on the absorbance of 
Charge transfer complex 
 
Effect of solvent 
1,2-Dichloroethane was found to be an ideal solvent in case of 
iodine, because it is favourable for the formation of tri-iodide ion 
pair (inner complex). Dichloromethane and chloroform produced 
lower absorbance readings. Polar solvents such as acetonitrile and 
alcohols were found to be unsuitable as their blanks with iodine 
gave high absorbance. It is obvious that, the rate of transformation of 
outer complex to inner complex is in the order of 1,2-
dichloroethane>dichloromethane>chloroform [31]. There is actually 
a considerable decrease in the energy of activation along with an 
increased dielectric constant εr of the medium; in 1,2-dichloroehane 
(ε r = 10.2) the transformation of inner complex proceeds much 
faster than that in dichloromethane (ε r = 9.1) and chloroform (ε r = 
4.8). This is in support of the proposed three-steps mechanism. In 
fact, the resulting charged transition states in going from the outer 
complexes to the inner ones (as the rate determining step of the 
mechanism) are expected to be more stabilized in 1,2-
dichloroethane because of higher solvating ability and relative 
permittivity than dichloromethane and chloroform [32]. 
For p-CLA and TCNQ complex formation, acetonitrile afforded 
maximum sensitivity, due to its high dielectric constant (37.5) [33] 
when compared with all other solvents (benzene, chloroform, 
ethylene chloride and methanol), a property which is known to 
promote the dissociation of the original charge transfer complexes 
to the radical anions in addition to the high solvating power of the 
reagent and drug. On the other hand, methanol affords maximum 
sensitivity and full color development with DDQ. In addition, it is a 
good solvent for the reagent.  
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Effect of reaction time 
Complete color development, was attained instantaneously using 
iodine, whereas for DDQ and p-CLA, complete color development 
was attained after 5.0 min at (25 ± 2 °C). For TCNQ complete color 
development was attained after 90 min. To consume the time 
required for complete color development heating in a water bath at 
60 ± 2 °C for 10 min. The color remained stable for 3.0, 2.0 and 4.0 h 
using TCNQ, DDQ and p-CLA, respectively. In the case of iodine, the 
yellow color remained stable at least a further 1.0 h in the dark.  
Molar ratio of the reaction  
Job's continuous variation graph [26] for the reaction between VOR 
and different reagents (fig. 6) shows that the interaction occurs on 
an equimolar basis via the formation of a charge transfer complex 
(1:1). The colored reaction product can be represented, taking TCNQ 
as an example, by Scheme 1. A more detailed examination was made 
for VOR complexes with the studied acceptors. The absorbance of 
the complex was used to calculate the association constant using the 
Benesi-Hildebrand equation [34]. 
 
Where [Ao] and [Do] are the total concentrations of the interacting 
species, AλAD and ελADare the absorbance and molar absorptivity of 
the complex at their λmax, and Kc AD is the association constant of the 
complex. On plotting the values of [Ao]/AλAD versus 1/[Do], a line 
was obtained with slope equals  ً◌(ελAD KcAD)-1 and intercept of this 
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Fig. 6: Continuous variation plots for the reaction of VOR with 
Iodine, p-CLA, DDQ and TCNQ. λ= 364, 538, 461 and 840 nm, 



































Scheme 1: Proposed reaction pathway for the formation of 
charge transfer complex between VOR and TCNQ 
 
The calculated association constants are recorded in table 3, 
whereas the molar absorptivities were comparable with those 
obtained from the regression line equation of Beer's law. The low 
values obtained for the association constants are common in these 
complexes due to the dissociation of the original donor–acceptor 
complex to the radical anion. 
Validation of the proposed method  
Linearity, detection, and quantitation limits 
Following the proposed experimental conditions, the relationship 
between the absorbance and concentration was quite linear in the 
concentration ranges 2.0-120 μg mLP−1P as showed in table 1. The 
regression equations were derived using the least-squares method 
[35]. The intercept (a), slope (b), correlation coefficient (r), molar 
absorptivities (ε), and sandell sensitivity values are summarized in 
table 2. The percentage recoveries of the pure drugs using the 
proposed methods compared with that given by the reported 
methods are illustrated in table 1. The validity of the proposed 
methods was evaluated by statistical analysis [36], between the 
results achieved from the proposed methods and that of the 
reported methods. Regarding the calculated Student’s t-test and 
variance ratio F-test (Table 1), there is no significant difference 
between the proposed and reported methods regarding accuracy 
and precision. 
 
Table 1: Statistical Analysis for determination of VOR by the proposed methods 
Parameters Iodine DDQ p-CLA TCNQ 
Wavelengths λR maxR (nm) 364 461 538 840 
Solvent 1,2- dichloroethane Methanol Acetonitrile Acetonitrile 
Color stability 1.0 2.0 4.0 3.0 
Beer’s law limits (µg mLP−1P) 2.0-24 5.0-90 5.0-120 2.0-20 
Ringbom optimum concentration range (µg mLP−1P) 5.0-20 10-80 10-110 4.0-16 
Molar absorptivity ε, (L/molP-1P cmP-1P) x 10P4 0.8535 0.2839 0.1915 1.0872 
SandellP,Ps sensitivity (ng cmP-2P) 40.92 12.30 18.24 32.13 
Regression equation PaP     
Slope (b) 0.0242 0.0088 0.0049 0.0313 
Intercept (a) -0.0003 - 0.0084 0.0075 -0.0004 
Correlation coefficient (r) 0.9997 0.9996 0.9994 0.9999 
Mean ± SD 99.50 ± 0.74 99.70± 0.86 99.80±0.98 99.60±1.14 
Relative standard deviation, RSD% 0.74 0.86 0.98 1.14 
Relative error, RE% 0.78 0.90 1.03 1.20 
LOD, (µg mLP−1P) Pb 0.36 0.86 1.23 0.43 
LOQ, (µg mLP−1P)Pb 1.20 2.87 4.1 1.43 
Calculated t-valuePc 0.23 0.57 0.70  0.34  
Calculated F-value Pc 1.55 1.14 1.13 1.54 
P
a
P A = a + bC, where C is the concentration in µg mLP−1P, A is the absorbance units, a is the intercept, b is the slope, Pb P LOD, limit of detection; LOQ, limit of 
quantification; ε, molar absorptivity, PcP The theoretical values of t and F are 2.57 and 5.05, respectively at confidence limit at 95% confidence level 
and five degrees of freedom (p= 0.05). 
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The limit of detection (LOD) is defined as the minimum level at 
which the analyte can be reliably detected was calculated using the 
following equation [36, 37], and listed in table 1:  
LOD = 3s / k 
Where s is the standard deviation of replicate determination values 
under the same conditions as for the sample analysis in the absence 
of the analyte and k is the sensitivity, namely the slope of the 
calibration graph. In accordance with the formula, the detection 
limits were found to be 0.36, 0.86, 1.23 and 0.43 µg mL−1 using I2, 
DDQ, p-CLA and TCNQ, respectively. The limits of quantization 
(LOQ) is defined as the lowest concentration that can be measured 
with acceptable accuracy and precision [36, 37], 
LOQ = 10 s / k 
According to this equation, the limit of quantization was found to be 
1.20, 2.87, 4.10 and 1.43 µg mL−1 using I2
The intra-day and inter-day precision and accuracy results show 
that the proposed methods have good repeatability and 
reproducibility (Table 2). 
, DDQ, p-CLA and TCNQ, 
respectively, respectively. 
Accuracy and precision  
The accuracy and precision of the methods were evaluated by 
performing six replicate analyses on pure drug solution at three 
different concentration levels (within the working range). 
Percentage relative standard deviation (RSD%) as precision and 
percentage relative error (RE %) as accuracy of the proposed 
spectrophotometric methods were calculated. The relative standard 
deviation (RSD) values were less than 2.0% in all cases, indicating 
good repeatability of the suggested methods. This level of precision 
of the proposed methods was adequate for the quality control 
analysis of VOR. The percentage relative error calculated using the 
following equation:  
RE % = [(founded – added) / added] x 100 
Ruggedness and robustness 
The robustness of the procedures was assessed by evaluating the 
influence of small variation of experimental variables, i. e., 
concentration of reagents and reaction time and the effect of the 
changes was studied on the absorbance of the complex systems. In 
these experiments, one experimental parameter was changed while 
the other parameters were kept unchanged, and the changes had 
negligible influence on the results as revealed by small intermediate 
precision values expressed as RSD (≤ 3.0%).  
Method ruggedness was demonstrated having the analysis done by 
three analysts, and also by a single analyst performing analysis on 
three different spectrophotometer instruments in the same 
laboratory. The robustness and the ruggedness were checked at 
three different drug levels. The intermediate precision, expressed as 
percent RSD was in the range 1.25–2.80%, which is a measure of 
robustness and ruggedness was within the acceptable limits as 
shown in the table 3. This provided an indication of the reliability of 
the proposed methods during routine work. 
Recovery studies 
The accuracy and validity of the proposed methods were further 
ascertained by performing recovery studies. Pre-analyzed tablet powder 
was spiked with pure VOR at different levels and the total was 
determined by the proposed methods using the standard addition 
technique. The percent recovery of pure VOR added was in the range 
99.27–99.90% with relative standard deviation of 0.41–0.73% (Table 5) 
indicating that the recoveries were good, and that the co- formulated 
substance and common excipients did not interfere in the determination.  
 
Table 2: Evaluation of intra-day and inter-day precision and accuracy obtained by the proposed methods. 










Er % a 





Er % a 
Confidence Limit b 
Iodine 5.0 99.55 0.53 -0.45 4.98±0.03 99.75 0.80 -0.25 4.99±0.04 
15 100.30 0.90 0.30 15.05±0.13 99.40 1.15 -0.60 14.91±0.16 
25 99.80 1.05 -0.20 24.95±0.25 99.60 1.40 -0.40 24.95±0.33 
DDQ 20 100.10 0.74 0.10 20.02±0.14 100.40 0.79 0.40 20.08±0.15 
40 99.30 0.97 -0.70 39.72±0.37 99.10 0.81 -0.90 39.64±0.31 
80 99.70 1.30 -0.30 79.76±0.99 99.80 0.63 -0.20 79.84±0.48 
p-CLA 30 99.50 0.85 -0.50 29.85 ± 0.24 99.90 0.59 -0.10 29.97 ± 0.17 
60 100.50 0.98 0.50 60.30 ± 0.56 99.60 0.69 -0.40 59.76 ± 0.39 
90 99.60 1.20 -0.40 89.64 ± 1.02 99.30 0.92 -0.70 89.37 ± 0.78 
TCNQ 5.0 99.80 0.56 -0.20 4.99 ± 0.03 100.20 0.47 0.20 5.01 ± 0.02 
 10 100.30 0.90 0.30 10.03 ± 0.09 100.50 0.70 0.50 10.05 ± 0.07 
 15 99.50 1.50 -0.50 14.93 ± 0.21 99.40 1.50 -0.60 14.91 ± 0.21 
a Mean of six determination, RSD%, percentage relative standard deviation; Er%, percentage relative error, b
Method 
 Mean ± standard error. 
 






Parameters altered Inter-analysts (RSD, %) Inter-instruments (RSD, %) 
   Volume of reagent Reaction time a (n = 3) b (n = 3) 
Iodine 5.0 1.25 2.16 2.08 1.85 
 15 1.18 2.24 2.28 1.73 
 25 1.46 1.88 2.50 1.90 
DDQ 20 1.52 1.90 1.82 2.14 
 40 1.73 2.42 1.66 2.40 
 80 1.86 2.10 1.48 2.60 
p-CLA 30 1.90 1.65 2.02 2.10 
 60 1.50 1.80 2.60 1.87 
 90 1.26 1.55 2.74 1.79 
TCNQ 5.0 1.30 1.72 1.94 2.20 
 10 1.95 1.84 1.84 2.64 
 15 2.04 2.26 1.98 2.80 
AThe volumes of I2, p-CLA or TCNQ added were 1.0±0.1 mL and the volume of DDQ added was 2.0±0.2 mL, b the reaction times were 5.0±1.0 min for 
I2, p-CLA or DDQ and 10±1.0 min for TCNQ.  
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Table 4: Application of the standard addition technique for the determination of VOR in dosage forms using the proposed methods 
Sample Iodine DDQ  p-CLA  TCNQ   Reference 
method  




































2.0 - 99.20 10 - 99.40 10 - 99.00 2.0 - 98.90  
 4.0 99.50  10 99.90  20 100.70  2.0 99.30  
 8.0 98.80  20 99.30  40 100.50  4.0 99.80  
 16 98.60  40 99.50  60 99.60  8.0 99.90  
 24 99.80  60 100.20  80 100.40  12 100.20  
 28 99.70  80 99.10  100 99.20  16 100.40  
Mean ± SD    99.27±0.49   99.57±0.41   99.90 ±0.73   99.75 ±0.56 99.56  
V   0.24   0.168   0.533   0.31 0.15 
R. S. D%   0.49   0.41   0.73   0.56 0.39 
S. E   0.20   0.167   0.30   0.23 0.16 
t-valuePb   1.04   0.04   0.92   0.91  
F-valuePb   1.58   1.11   3.5   2.06  
P
a
PAverage of six determinations, Pb P The theoretical values of t and F are 2.57 and 5.05, respectively at confidence limit at 95% confidence level and five degrees of freedom (p= 0.05). 
 
Specificity and interference 
The proposed spectrophotometric methods have the advantages that the measurements in all of 
these methods are performed in the visible region, away from the UV-absorbing interfering 
substances that might be co-extracted from VOR containing dosage forms. Regarding the 
interference of the excipients and additives usually presented in pharmaceutical formulation 
(lactose monohydrate, starch, croscarmellose sodium, povidone, magnesium stearate and a 
coating containing hypromellose, titanium dioxide, lactose monohydrate and triacetin), the 
energy of the charge transfer (ECT) depends on the ionization potential (IP) of the donor and the 
electron affinity of the acceptor (EA), hence the λRmax Rvalues of the other π-donors mostly differ 
from that of the investigated compounds if they are able to form CT complexes. Preliminary 
experiments showed that all additives and excipients did not form CT complexes with the 
studied acceptors indicating the high selectivity of the proposed methods and applicability to use 
for routine determination in pure and in dosage forms. 
Application of the proposed method to the analysis of tablets 
The obtained satisfactory validation results made the proposed procedures suitable for the 
routine quality control analysis of VOR and its pharmaceutical formulations (V fend® tablet). 
The results obtained by the proposed methods were statistically compared with those obtained 
by the reported method (Ahmed et al., 2010). The obtained mean values of the labeled amounts 
ranged from 99.27±0.49% to 99.90 ±0.73% (Table 4). In the t- and F-tests, no significant 
differences were found between the calculated and theoretical values of both the proposed and 
the reported methods at 95% confidence level [38]. This indicated similar precision and accuracy 
in the analysis of VOR in its formulations. It is evident from these results that all the proposed 
methods are applicable to the analysis of VOR in its tablets with comparable analytical 
performance. However, the critical recommendations of some of these methods might be based 
on the experimental conditions (e. g. reaction time), and the ultimate sensitivity that determines 
the amount of specimen required for analysis. For example, the methods involving DDQ and p-
CLA are recommended whenever rapid analysis is required; this because they have very short 
reaction time. The method involving TCNQ is recommended, as high sensitivity is required on the 
expense of the analysis time. 
DISCUSSION  
The color of iodine in 1,2-dichloroethane is violet showing absorption maximum (λRmaxR) at 
520 nm. This color was immediately changed into lemon yellow, and the absorption spectrum of 
VOR-IR2R reaction product showed absorption peaks at 292 and 364 nm. This change in color, and 
the appearance of these two peaks were attributed to the formation of charge-transfer complex 
between the VOR and IR2R, having an ionized structure DIP+P … IR3RP−P, taking into account that the 
absorption spectrum of IR3RP−P in 1,2-dichloroethane showed the two absorption maxima at 292 and 
364 nm. This complex should originate from an early intermediated outer complex D…IR2R, 
according to the following scheme:  
 
The interaction of VOR with selective polyhaloquinone and polycyanoquinone π-acceptors in 
non-polar solvents such as 1,2-dichloroethane was found to produce colored charge-transfer 
complexes with low molar absorptivity values. In polar solvents such as methanol or acetonitrile, 
complete electron transfer from the VOR (D), as an electron donor, to the acceptor moiety (A) 
takes place with the formation of intensely colored radical ions with high molar absorptivity 
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The dissociation of the (D–A) complex was promoted by the high 
ionizing power of the polar solvent and the resulting peaks in the 
absorption spectra of VOR-acceptor reaction mixtures were similar 
to the maxima of the radical anions of the acceptors obtained by the 
iodide reduction method [29]. 
Chloranilic acid (p-CLA) exists in three ionic forms, the neutral 
yellow-orange H2A at very low pH, the dark purple HA− which is 
stable at pH 3.0 and a colorless A2−
H
, which is stable at high pH; these 
transformations are illustrated in the following scheme 
2A H++HA−  (violet),
HA− H++A2−  
Since the interaction of VOR with p-CLA in acetonitrile gave a violet 
product, it might be concluded that HA
(colorless).
−
1. Sweetman SC. Martindale, The Complete Drug Reference, 35
 was the form of p-CLA 
involved in the reaction described herein. 
CONCLUSION 
The charge-transfer complexation reaction of VOR as electron donor 
and some electron acceptors has been investigated. The obtained 
colored complexes were utilized in the development of four simple, 
accurate and sensitive with good precision and accuracy 
spectrophotometric methods for the analysis of VOR in pure form as 
well as in dosage forms. With these methods, one can do the analysis 
at low cost without losing accuracy. The proposed methods can be 
used as alternative methods to the reported ones for the routine 
determination of Vfend® tablet. This encourages their successful 
use in routine analysis of these drugs in quality control laboratories 
and they involve very simple procedures. 
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